Ligand Pharmaceuticals, Inc. (LGND)
201.62
+1.69
(+0.85%)
USD |
NASDAQ |
Apr 06, 09:35
Ligand Pharmaceuticals Max Drawdown (5Y) : 72.85% for March 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Amicus Therapeutics, Inc. | 77.34% |
| ADMA Biologics, Inc. | 84.37% |
| Intuitive Surgical, Inc. | 49.90% |
| Globus Medical, Inc. | 47.91% |
| Establishment Labs Holdings, Inc. | 75.42% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 1.578 |
| Beta (5Y) | 1.181 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 41.93% |
| Historical Sharpe Ratio (5Y) | 0.2815 |
| Historical Sortino (5Y) | 0.5461 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 16.02% |